2024 HCPCS Code J7513
Daclizumab, parenteral, 25 mg
| Short Description | Daclizumab, parenteral |
| HCPCS Coverage Code | D - Special coverage instructions apply |
| HCPCS Action Code | N - No maintenance for this code |
| HCPCS Action Effective Date | January 01, 2018 |
| HCPCS Code Added Date | January 01, 1999 |
| HCPCS Pricing Indicator Code | 51 - Drugs |
| HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
| HCPCS Coverage Issues Manual Reference Section Number | |
| HCPCS Type Of Service Code | 1 - Medical care |
| HCPCS Anesthesia Base Unit Quantity | 0 |
Check Similar HCPCS Codes
- J0390 - Chloroquine injection
- J0391 - Inj, artesunate, 1mg
- J0395 - Arbutamine hcl injection
- J0400 - Aripiprazole injection
- J0401 - Inj, abilify maintena, 1 mg
- J0402 - Inj, abilify asimtufii, 1 mg
- J0456 - Azithromycin
- J0457 - Injection, aztreonam, 100 mg
- J0461 - Atropine sulfate injection
- J0470 - Dimecaprol injection
- J0475 - Baclofen 10 mg injection
- J0476 - Baclofen intrathecal trial
- J0480 - Basiliximab
- J0485 - Belatacept injection
- J0490 - Belimumab injection
- J0491 - Inj anifrolumab-fnia 1mg
- J0500 - Dicyclomine injection
- J0515 - Inj benztropine mesylate
- J0517 - Inj., benralizumab, 1 mg
- J0520 - Bethanechol chloride inject